Duplex follow-up of patients with DVT: Does it have clinical significance?

Seminars in Vascular Surgery

Volumn 14, Issue 3, 2001, Pages 215-221

  Meissner, Mark H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DISEASE COURSE; DOPPLER ECHOGRAPHY; DRUG CONTRAINDICATION; FOLLOW UP; GASTROCNEMIUS MUSCLE; HIGH RISK PATIENT; PRIORITY JOURNAL; RECANALIZATION; RECURRENT DISEASE; REVIEW;

EID: 0034811215     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/svas.2001.25493     Document Type: Review

References (46)

1. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative
2. Propagation, rethrombosis, and new thrombus formation after acute deep venous thrombosis
3. Propagation of deep venous thrombosis by duplex ultrasonography
4. Venous thrombus stability during acute phase of therapy
5. A simple ultrasound approach for detection of recurrent proximal vein thrombosis
6. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning
7. Spontaneous lysis of deep venous thrombi: Rate and outcome
8. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancent
9. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: Preliminary results
10. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline
11. The fate of calf vein thrombosis
12. Calf-vein thrombosis
13. Antithrombotic therapy for venous thromboembolic disease
14. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis
15. Free-floating ileofemoral thrombus. A risk of pulmonary embolism
16. Recurrent pulmonary embolism. A prospective study
17. Free-floating thrombus and pulmonary embolism
18. Floating thrombi: Diagnosis and follow-up by duplex ultrasound
19. Free-floating deep venous thrombosis. A retrospective analysis
20. Clinical significance of free-floating venous thrombi
21. Venous duplex imaging follow-up of acute symptomatic deep vein thrombosis of the leg
22. The diagnosis of acute, recurrent, deep venous thrombosis: A diagnostic challenge
23. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism
24. Recurrent venous thromboembolism after deep venous thrombosis. Incidence and risk factors
25. The long term clinical course of acute deep venous thrombosis
26. Venous duplex scanning
27. Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280
28. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis
29. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism
30. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
31. Oral anticoagulation in venous thromboembolism: Decisions based on more than mere feelings
32. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
33. Oral anticoagulation after a first episoe of venous thromboembolism: How long? How strong?
34. Treatment of deep vein thrombosis: Is thrombosis regression a desirable endpoint?
35. Low molecular weight heparins could be important in cancer
36. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
37. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis
38. Deep venous insufficiency: The relationship between lysis and subsequent reflux
39. Determinants of chronic venous disease after acute deep venous thrombosis
40. Long-term outcome of deep-vein thrombosis
41. Optimal duration of oral anticoagulant therapy: A randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis
42. Clinical utility of real time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis
43. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: A one- to six-year follow-up
44. Recurrent deep venous thrombosis: Limitations of US
45. The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg
46. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin. A retrospective analysis